SAGE Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Al-righty. Let's go ahead and get started. Welcome, everybody, to the Tuesday morning of the JPMorgan Healthcare Conference -- 41st Annual JPMorgan Healthcare Conference.
My name is Anupam Rama, I'm one of the senior biotech analysts here at JPMorgan. I'm joined by my squad, Malcolm Kuno and Priyanka Grover. The next presenting company is Sage. Presenting on behalf of the company, we have CEO, Barry Greene. Barry?
Thanks, Anupam, and squad. And thanks for the organizers of JPMorgan for having us here today. It's great to be here live in sunny San Francisco, live again. I'm Barry Greene, as Anupam said, the CEO of Sage Therapeutics.
It's an absolute pleasure to provide an update on the extraordinary progress that we at Sage are making, progressing a pipeline of novel brain health medicines. I will be making forward-looking statements.
As we stand here as an industry, we can be
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |